Q-Line Biotech Limited IPO
ListedSME
102.42×
Subscribed
Price band
₹326 – ₹343
Open – close
21 May 2026
to 25 May 2026
Listing
29 May 2026
What the filing actually says
Our read of the offer document and the exchange data — not the issuer's summary of itself
We can't judge this issue yet. A verdict needs at least three independent dimensions — valuation, growth, profitability, balance sheet, issue structure, governance or demand — and this issue does not yet publish enough of them for a read that would mean anything. No offer document for this issue has been published yet. A confident score from two fields would be worse than this notice.
Dates
The issuer's tentative timetable — a date passing is not confirmation the step completed
- Opens21 May 2026
- Closes25 May 2026
- Listing29 May 2026
Demand and your odds
How the book filled, and what that means for an application
Subscription by category
Qualified institutionalQIB123.94x
Non-institutionalNII / HNI145.98x
Big NIIabove ₹10L178.29x
Small NII₹2L – ₹10L81.35x
Retail individualRII71.44x
2,35,655 applications received — how many people bid, as opposed to how much money did. Exchange figures as of 25 May 2026.
Chance of allotment
Retail71.44× subscribed
~1 in 71.4
Retail is 71.44× subscribed. Allotment is a lottery on a single lot, so roughly 1 in 71.4 applications gets one lot. Bidding for extra lots does not improve these odds.
HNI / NII145.98× subscribed
~1 in 146
HNI is 145.98× subscribed. This category is allotted proportionately, so a bid receives roughly 1/146 of the shares applied for, subject to the minimum-lot draw.
Derived from SEBI's allotment mechanics and the subscription figures beside it. Retail allotment is a lottery on a single lot, so applying for more lots does not improve your chance of getting something.
The offering
Terms, structure and who is selling
Terms
Price band₹326 – ₹343
Listing atSME platform
Company & valuation
ISININE1G2W01011
What happened to comparable issues
The last 8 issues to list with a recorded opening price, most comparable first
Median listing gain
+0.0%
Listed up
3 of 8
Best
+90.0%
SpectraA Technology
Worst
-1.0%
Injecto Polymers
SpectraA Technologysame segment
304.1× sub+90.0%
Kheria Autocompsame segment
2.5× sub+3.9%
Shakti Polytarpsame segment
11.9× sub-0.2%
Vama Wovenfabsame segment
2.5× sub+0.0%
Century Businesssame segment
57.9× sub+0.0%
Injecto Polymerssame segment
1.2× sub-1.0%
Om Galaxysame segment
2.1× sub+0.2%
Raksan Transformerssame segment
47.4× sub+0.0%
Past issues are context, not a forecast — this issue is a different company at a different price. We show it because "how have issues like this one actually opened" is a question with a real answer, and grey-market premium is not that answer.
Common questions
How many times is the Q-Line Biotech Limited IPO subscribed?
Q-Line Biotech Limited is subscribed 102.42× overall (QIB 123.94×, NII 145.98×, retail 71.44×). Subscription keeps changing until the issue closes; the final basis of allotment is published by the registrar.
What are the chances of allotment in the Q-Line Biotech Limited IPO?
The retail portion is subscribed 71.44×, so allotment is by lottery and the odds of receiving at least one lot are roughly 1 in 71. Applying for more lots does not improve the chance of getting something — every retail applicant competes for the same single minimum lot.
Disclaimer. Figures are compiled from the issuer's offer document and exchange-published bidding data. Subscription changes until the issue closes, and the final basis of allotment is published by the registrar. Grey-market premium is unofficial and is not a forecast. Nothing here is investment advice or a recommendation — read the offer document and consult a SEBI-registered adviser before applying.